SMTL ID : 6fmj.2 (3 other biounits)

pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl) benzyl)pyrrolidine-2-carboxamide (ligand 3)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x DV5: (2~{S},4~{R})-1-[(2~{S})-2-acetamidopropanethioyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)

DV5.1: 12 residues within 4Å: Chain C: W.37, F.40, Y.47, P.48, L.50, R.56, I.58, H.59, S.60, Y.61, H.64, W.66 9 PLIP interactions: 9 interactions with chain C Hydrophobic interactions: C:W.37, C:I.58, C:I.58, C:W.66 Hydrogen bonds: C:W.37, C:Y.47, C:H.59, C:Y.61 pi-Stacking: C:Y.47

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Soares, P. et al., Thioamide substitution to probe the hydroxyproline recognition of VHL ligands. Bioorg. Med. Chem. (2018)

Release Date

2018-04-11

Peptides

Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

C
F

Elongin-B

Elongin-C

von Hippel-Lindau disease tumor suppressor

Related Entries With Identical Sequence